Alphatec Holdings, Inc.
Alphatec Holdings, Inc. (Nasdaq: ATEC) is a medical technology company that designs and develops products and technologies for surgical treatment of spine disorders. Its portfolio supports procedures addressing spinal decompression, stabilization and alignment, and includes surgical access systems, patient… From the company’s description.
Over the twelve months to Sep 30, 2026, Alphatec Holdings, Inc. reported revenue of $839.72M, up 15.3% from a year earlier, and a net loss of $86.89M. Its operating margin was −3.6%, and operations generated $61.34M in cash. In fiscal 2025, it reported revenue of $764.15M, up 25.0% from fiscal 2024, and a net loss of $143.36M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Alphatec Holdings, Inc. does
In the company’s own words
Alphatec Holdings, Inc. (Nasdaq: ATEC) is a medical technology company that designs and develops products and technologies for surgical treatment of spine disorders. Its portfolio supports procedures addressing spinal decompression, stabilization and alignment, and includes surgical access systems, patient positioners, implants, fixation systems and biologics. The company also offers technologies for imaging, surgical planning, intraoperative nerve monitoring, navigation and robotics through its InformatiX platform, which includes EOS imaging, EOS Insight, SafeOp and Valence. Its customers include spine surgeons, hospitals and healthcare systems; surgeons typically select products, while hospitals are generally invoiced. Alphatec sells through independent sales agents and direct sales representatives. Its approach-specific offerings include Prone TransPsoas, Lateral TransPsoas and Midline ALIF procedures, alongside products for cervical, deformity and other spine applications. The company acquired SafeOp and EOS imaging and acquired Valence in 2023. For fiscal 2025, Alphatec reported revenue of $764.2 million.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- CARLSBAD, CA
- Fiscal year end
- December
- CIK
- 1350653
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Alphatec Holdings, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Alphatec Holdings, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Alphatec Holdings, Inc.’s bonds, as funds hold them
Funds report holding 2 issues of Alphatec Holdings, Inc.’s debt, $76.43M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 0.75%, maturing 2026 to 2030.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Alphatec Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Alphatec Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Alphatec Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”